Same-Day Discharge for Patients Undergoing Subxiphoid Thoracoscopic Thymectomy for Small Tumours Without Myasthenia Gravis: A Prospective, Single-Arm Clinical Trial 

This single-center prospective trial evaluated same-day discharge (SDD) following subxiphoid thoracoscopic thymectomy in 39 patients with thymic tumors. The SDD completion rate was 92.3percent, with all patients achieving R0 resection. The perioperative complication rate was 5.6 percent, and only one patient required readmission within 30 days due to pneumothorax. The median hospital stay was just 11 hours, with median medical costs amounting to 19,400 renminbi (approximately EU €2,400). These findings suggest that SDD may be safe and feasible for selected patients undergoing this procedure, although larger studies are needed for confirmation.